DUBLIN, June 21, 2018 /PRNewswire/ --
The "Global Blood Processing Devices and Consumables Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.
Blood processing devices and consumables market projected to reach US$ 64.25 Bn by 2026 with CAGR of 7.9% during the forecast period from 2018 to 2026.
The demand for automated blood processing devices is higher in the market due to their better accuracy, faster activity result delivery, and specificity. At present, blood cell processers are the largest revenue generating segment due to technological advancement in laboratory devices. Blood bags is the fastest growing segment, as it guarantees sterility in transfusion and have effectively supplanted the utilization of glass bottles in transfusion process.
Along these lines, blood bags have picked up part of force because of its ability in keeping up blood security and quality. Global blood processing devices and consumables market from 2018 to 2026 study is based on thorough analysis with insights from manufacturing stockholders. The comprehensive study includes the growth scenarios and market landscape during the forecast period from 2018 to 2026.
As indicated by WHO, 16 nations around the globe can't screen the donated blood for at least one or more contaminations. WHO recognized sporadic supply of test kits is the factor ascribed to this deficiency. The blood and transfusion safety program of WHO bolsters nations in creating national blood system to guarantee quality blood processing and transfusion operations.
Geographically, North America held the largest share in terms of revenue in 2017 and projected to remain stable during the forecast period due to greater demand for specific blood-derived products, and the domicile of major market players. However, the supremacy of North America will be clearly confronted by the Europe. Owing to the strong government support in terms of evolved national blood policy' covering safety and quality of blood transfusion, there are high chances for market penetration in countries like Mexico, India, and China to the market occupiers at present having a grip in developed countries.
The need for blood processing devices and consumables has become prominent in the Asia Pacific owing to continuous rise in the population, high incidence of infectious diseases and number of awareness programs conducted in the region that will boost market during the forecast period from 2018 to 2026.
Key Topics Covered:
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Segmentation
1.4. Research Methodology
Chapter 2. Executive Summary
2.1. Global Blood Processing Devices and Consumables Market Portraiture
2.2. Global Blood Processing Devices and Consumables Market, by Product Type, 2017 (US$ Bn)
2.3. Global Blood Processing Devices and Consumables Market, by Geography, 2017 (US$ Bn)
Chapter 3. Global Blood Processing Devices and Consumables Market Overview, 2016-2026 (US$ Bn)
3.1. Overview
3.2. Market Drivers
3.2.1. Growing Incidence of Infectious Diseases
3.2.2. Driver 2
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape, by key players, 2017
Chapter 4. Global Blood Processing Devices and Consumables Market, by Product Type, 2016 - 2026 (US$ Bn)
4.1. Overview
4.2. Devices
4.2.1. Blood cell processors
4.2.2. Blood cell analyzers
4.2.3. Blood bank refrigerators
4.2.4. Freezers
4.2.5. Warmers
4.2.6. Hematocrit centrifuges
4.3. Consumables
4.3.1. Reagents
4.3.2. Blood Lancets
4.3.3. Blood Mixer
4.3.4. Blood Collection Tubes
4.3.5. Blood Collection Needles
4.3.6. Blood Bags
4.3.7. Others(Sedimentation Tubes, Slides, and Vials)
Chapter 5. Global Blood Processing Devices and Consumables Market, by Geography, 2016 - 2026 (US$ Bn)
Chapter 6. Company Profiles
6.1. Becton, Dickinson and Company
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Abbott Laboratories
6.3. Bio-Rad Laboratories
6.4. Thermo Fisher Scientific
6.5. Beckman Coulter
6.6. Grifols International, S.A.
6.7. Haemonetics Corporation
6.8. Fresenius Kabi
6.9. Immucor, Inc.
6.10. Macopharma
6.11. F. Hoffmann-La Roche AG
6.12. Stago
6.13. BioMrieux
6.14. Danaher Corporation
6.15. Thermogenesis Corporation
6.16. Terumo Corporation
For more information about this report visit https://www.researchandmarkets.com/research/jgdk7v/global_blood?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets